Stromal Sarcoma — Trials

Stromal Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 40%
Top sponsor: Centre Leon Berard
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03241745	A Study of Nivolumab in Selected Uterine Cancer Patients	completed	Phase 2	35	Memorial Sloan Kettering Cancer CenterOTHER	1	Dec 27, 2024	clinicaltrials
NCT03926936	FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study(FUCHSia)	completed	Phase 2	17	Frederic AmantOTHER	2	May 28, 2024	clinicaltrials